Global Molecular Diagnostics Raw Material Market Research Report 2023

Publication ID:

PB510230333

Publication Date:

October 2, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Molecular Diagnostics Raw Material market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Molecular Diagnostics Raw Material 91制片厂.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Molecular Diagnostics Raw Material market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
TOYOBO Biotech
Vazyme
Fapon Biotech Inc
New England Biolabs
Segment by Type
Reverse Transcriptase
DNA Polymerase
PCR Excipients
Other
Segment by Application
Disease Diagnosis
Adjuvant Therapy
scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Molecular Diagnostics Raw Material report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Raw Material Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Reverse Transcriptase
1.2.3 DNA Polymerase
1.2.4 PCR Excipients
1.2.5 Other
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Raw Material Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Disease Diagnosis
1.3.3 Adjuvant Therapy
1.3.4 scientific Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Raw Material Market Perspective (2018-2029)
2.2 Molecular Diagnostics Raw Material Growth Trends by Region
2.2.1 Global Molecular Diagnostics Raw Material Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Molecular Diagnostics Raw Material Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnostics Raw Material Forecasted Market Size by Region (2024-2029)
2.3 Molecular Diagnostics Raw Material Market Dynamics
2.3.1 Molecular Diagnostics Raw Material Industry Trends
2.3.2 Molecular Diagnostics Raw Material Market Drivers
2.3.3 Molecular Diagnostics Raw Material Market Challenges
2.3.4 Molecular Diagnostics Raw Material Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Raw Material Players by Revenue
3.1.1 Global Top Molecular Diagnostics Raw Material Players by Revenue (2018-2023)
3.1.2 Global Molecular Diagnostics Raw Material Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Raw Material Revenue
3.4 Global Molecular Diagnostics Raw Material Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Raw Material Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Raw Material Revenue in 2022
3.5 Molecular Diagnostics Raw Material Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Raw Material Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Raw Material Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Raw Material Breakdown Data by Type
4.1 Global Molecular Diagnostics Raw Material Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnostics Raw Material Forecasted Market Size by Type (2024-2029)
5 Molecular Diagnostics Raw Material Breakdown Data by Application
5.1 Global Molecular Diagnostics Raw Material Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnostics Raw Material Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Molecular Diagnostics Raw Material Market Size (2018-2029)
6.2 North America Molecular Diagnostics Raw Material Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Molecular Diagnostics Raw Material Market Size by Country (2018-2023)
6.4 North America Molecular Diagnostics Raw Material Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics Raw Material Market Size (2018-2029)
7.2 Europe Molecular Diagnostics Raw Material Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Molecular Diagnostics Raw Material Market Size by Country (2018-2023)
7.4 Europe Molecular Diagnostics Raw Material Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Raw Material Market Size (2018-2029)
8.2 Asia-Pacific Molecular Diagnostics Raw Material Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Molecular Diagnostics Raw Material Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Diagnostics Raw Material Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Raw Material Market Size (2018-2029)
9.2 Latin America Molecular Diagnostics Raw Material Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Molecular Diagnostics Raw Material Market Size by Country (2018-2023)
9.4 Latin America Molecular Diagnostics Raw Material Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Raw Material Market Size (2018-2029)
10.2 Middle East & Africa Molecular Diagnostics Raw Material Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Molecular Diagnostics Raw Material Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Diagnostics Raw Material Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Molecular Diagnostics Raw Material Introduction
11.1.4 Thermo Fisher Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 Promega
11.2.1 Promega Company Detail
11.2.2 Promega Business Overview
11.2.3 Promega Molecular Diagnostics Raw Material Introduction
11.2.4 Promega Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.2.5 Promega Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Molecular Diagnostics Raw Material Introduction
11.3.4 Roche Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Detail
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Molecular Diagnostics Raw Material Introduction
11.4.4 Bio-Rad Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.4.5 Bio-Rad Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Detail
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Molecular Diagnostics Raw Material Introduction
11.5.4 Takara Bio Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.5.5 Takara Bio Recent Development
11.6 Agilent
11.6.1 Agilent Company Detail
11.6.2 Agilent Business Overview
11.6.3 Agilent Molecular Diagnostics Raw Material Introduction
11.6.4 Agilent Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.6.5 Agilent Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Molecular Diagnostics Raw Material Introduction
11.7.4 Qiagen Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.7.5 Qiagen Recent Development
11.8 Fapon Biotech
11.8.1 Fapon Biotech Company Detail
11.8.2 Fapon Biotech Business Overview
11.8.3 Fapon Biotech Molecular Diagnostics Raw Material Introduction
11.8.4 Fapon Biotech Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.8.5 Fapon Biotech Recent Development
11.9 TOYOBO Biotech
11.9.1 TOYOBO Biotech Company Detail
11.9.2 TOYOBO Biotech Business Overview
11.9.3 TOYOBO Biotech Molecular Diagnostics Raw Material Introduction
11.9.4 TOYOBO Biotech Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.9.5 TOYOBO Biotech Recent Development
11.10 Vazyme
11.10.1 Vazyme Company Detail
11.10.2 Vazyme Business Overview
11.10.3 Vazyme Molecular Diagnostics Raw Material Introduction
11.10.4 Vazyme Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.10.5 Vazyme Recent Development
11.11 Fapon Biotech Inc
11.11.1 Fapon Biotech Inc Company Detail
11.11.2 Fapon Biotech Inc Business Overview
11.11.3 Fapon Biotech Inc Molecular Diagnostics Raw Material Introduction
11.11.4 Fapon Biotech Inc Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.11.5 Fapon Biotech Inc Recent Development
11.12 New England Biolabs
11.12.1 New England Biolabs Company Detail
11.12.2 New England Biolabs Business Overview
11.12.3 New England Biolabs Molecular Diagnostics Raw Material Introduction
11.12.4 New England Biolabs Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.12.5 New England Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
TOYOBO Biotech
Vazyme
Fapon Biotech Inc
New England Biolabs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.